These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 18716850)
1. Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia. Dhir M; Montgomery EA; Glöckner SC; Schuebel KE; Hooker CM; Herman JG; Baylin SB; Gearhart SL; Ahuja N J Gastrointest Surg; 2008 Oct; 12(10):1745-53. PubMed ID: 18716850 [TBL] [Abstract][Full Text] [Related]
2. MGMT-B gene promoter hypermethylation in patients with inflammatory bowel disease - a novel finding. Mokarram P; Kavousipour S; Sarabi MM; Mehrabani G; Fahmidehkar MA; Shamsdin SA; Alipour A; Naini MA Asian Pac J Cancer Prev; 2015; 16(5):1945-52. PubMed ID: 25773792 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients. Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937 [TBL] [Abstract][Full Text] [Related]
4. Validation of epigenetic markers to identify colitis associated cancer: Results of module 1 of the ENDCAP-C study. Beggs AD; Mehta S; Deeks JJ; James JD; Caldwell GM; Dilworth MP; Stockton JD; Blakeway D; Pestinger V; Vince A; Taniere P; Iqbal T; Magill L; Matthews G; Morton DG; EBioMedicine; 2019 Jan; 39():265-271. PubMed ID: 30473377 [TBL] [Abstract][Full Text] [Related]
5. Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists. Silva AL; Dawson SN; Arends MJ; Guttula K; Hall N; Cameron EA; Huang TH; Brenton JD; Tavaré S; Bienz M; Ibrahim AE BMC Cancer; 2014 Nov; 14():891. PubMed ID: 25432628 [TBL] [Abstract][Full Text] [Related]
14. Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients. Azuara D; Rodriguez-Moranta F; de Oca J; Sanjuan X; Guardiola J; Lobaton T; Wang A; Boadas J; Piqueras M; Monfort D; Galter S; Esteller M; Moreno V; Capellá G Inflamm Bowel Dis; 2013 Jan; 19(1):165-73. PubMed ID: 22532293 [TBL] [Abstract][Full Text] [Related]
15. Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients. Rawson JB; Manno M; Mrkonjic M; Daftary D; Dicks E; Buchanan DD; Younghusband HB; Parfrey PS; Young JP; Pollett A; Green RC; Gallinger S; McLaughlin JR; Knight JA; Bapat B Carcinogenesis; 2011 May; 32(5):741-7. PubMed ID: 21304055 [TBL] [Abstract][Full Text] [Related]
16. WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer. Serafino A; Moroni N; Zonfrillo M; Andreola F; Mercuri L; Nicotera G; Nunziata J; Ricci R; Antinori A; Rasi G; Pierimarchi P Oncotarget; 2014 Feb; 5(4):978-92. PubMed ID: 24657851 [TBL] [Abstract][Full Text] [Related]
17. New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients. Azuara D; Aussó S; Rodriguez-Moranta F; Guardiola J; Sanjuan X; Lobaton T; Boadas J; Piqueras M; Monfort D; Guinó E; Moreno V; Capellá G; de Oca J Inflamm Bowel Dis; 2018 Nov; 24(12):2555-2564. PubMed ID: 30099509 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia. Isidro RA; Cruz ML; Isidro AA; Baez A; Arroyo A; González-Marqués WA; González-Keelan C; Torres EA; Appleyard CB World J Gastroenterol; 2015 Feb; 21(6):1749-58. PubMed ID: 25684939 [TBL] [Abstract][Full Text] [Related]
19. Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix. van der Meide WF; Snellenberg S; Meijer CJ; Baalbergen A; Helmerhorst TJ; van der Sluis WB; Snijders PJ; Steenbergen RD Gynecol Oncol; 2011 Oct; 123(1):116-22. PubMed ID: 21726894 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung. Licchesi JD; Westra WH; Hooker CM; Machida EO; Baylin SB; Herman JG Carcinogenesis; 2008 May; 29(5):895-904. PubMed ID: 18308762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]